Cargando…

The Role of Cannabinoid Type 2 Receptors in Parkinson’s Disease

Parkinson’s disease (PD) is the second most frequent neurodegenerative disease and currently represents a clear unmet medical need. Therefore, novel preventive and therapeutic strategies are needed. Cannabinoid type 2 (CB2) receptors, one of the components of the endocannabinoid system, can regulate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Basile, Maria Sofia, Mazzon, Emanuela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687889/ https://www.ncbi.nlm.nih.gov/pubmed/36428554 http://dx.doi.org/10.3390/biomedicines10112986

Ejemplares similares

Cannabinoids and Neurogenesis: The Promised Solution for Neurodegeneration?
por: Valeri, Andrea, et al.
Publicado: (2021)

Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases
por: Giacoppo, Sabrina, et al.
Publicado: (2014)

The Role of Cytotoxic T-Lymphocyte Antigen 4 in the Pathogenesis of Multiple Sclerosis
por: Basile, Maria Sofia, et al.
Publicado: (2022)

Inosine in Neurodegenerative Diseases: From the Bench to the Bedside
por: Basile, Maria Sofia, et al.
Publicado: (2022)

Can cannabinoids be a potential therapeutic tool in amyotrophic lateral sclerosis?
por: Giacoppo, Sabrina, et al.
Publicado: (2016)

Cannabinoids in Parkinson's Disease
por: Stampanoni Bassi, Mario, et al.
Publicado: (2017)

On the Role of Central Type-1 Cannabinoid Receptor Gene Regulation in Food Intake and Eating Behaviors
por: Pucci, Mariangela, et al.
Publicado: (2021)

Modulating Stress Proteins in Response to Therapeutic Interventions for Parkinson’s Disease
por: Silvestro, Serena, et al.
Publicado: (2023)

Roles of the Cannabinoid System in the Basal Ganglia in Parkinson’s Disease
por: Wang, Mengya, et al.
Publicado: (2022)

The Role of Macrophages in Neuroinflammatory and Neurodegenerative Pathways of Alzheimer’s Disease, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis: Pathogenetic Cellular Effectors and Potential Therapeutic Targets
por: Mammana, Santa, et al.
Publicado: (2018)

Cannabinoids and Their Receptors in Skin Diseases
por: Yoo, Eun Hee, et al.
Publicado: (2023)

Cannabinoid CB2 Receptors are Involved in the Protection of RAW264.7 Macrophages Against the Oxidative Stress: An in Vitro Study
por: Giacoppo, Sabrina, et al.
Publicado: (2017)

Cannabinoid receptor type-1: breaking the dogmas
por: Busquets Garcia, Arnau, et al.
Publicado: (2016)

Caffeine: An Overview of Its Beneficial Effects in Experimental Models and Clinical Trials of Parkinson’s Disease
por: Schepici, Giovanni, et al.
Publicado: (2020)

Cannabinoids and Cannabinoid Receptors: The Story so Far
por: Shahbazi, Fred, et al.
Publicado: (2020)

Role of Cannabinoid Receptor Type 1 in Insulin Resistance and Its Biological Implications
por: Nagappan, Arulkumar, et al.
Publicado: (2019)

Commentary: Roles of the Cannabinoid System in the Basal Ganglia in Parkinson's Disease
por: Oikonomou, Panteleimon, et al.
Publicado: (2022)

The Role of Cannabinoid Receptors in the Descending Modulation of Pain
por: Palazzo, Enza, et al.
Publicado: (2010)

Assessment of select synthetic cannabinoid receptor agonist bias and selectivity between the type 1 and type 2 cannabinoid receptor
por: Zagzoog, Ayat, et al.
Publicado: (2021)

In Vitro Model of Neuroinflammation: Efficacy of Cannabigerol, a Non-Psychoactive Cannabinoid
por: Gugliandolo, Agnese, et al.
Publicado: (2018)

In Silico Analysis Reveals the Modulation of Ion Transmembrane Transporters in the Cerebellum of Alzheimer’s Disease Patients
por: D’Angiolini, Simone, et al.
Publicado: (2023)

“The Cannabinoid Receptors”
por: Reznicek, Gottfried
Publicado: (2010)

Cannabinoids affect the mouse visual acuity via the cannabinoid receptor type 2
por: Cécyre, Bruno, et al.
Publicado: (2020)

Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders
por: Ishiguro, Hiroki, et al.
Publicado: (2022)

Functional role of cannabinoid receptors in urinary bladder
por: Tyagi, Pradeep, et al.
Publicado: (2010)

Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection
por: More, Sandeep Vasant, et al.
Publicado: (2015)

Microglial Phenotypes and Their Relationship to the Cannabinoid System: Therapeutic Implications for Parkinson’s Disease
por: Kelly, Rachel, et al.
Publicado: (2020)

Altered Expression of Type-1 and Type-2 Cannabinoid Receptors in Celiac Disease
por: Battista, Natalia, et al.
Publicado: (2013)

Neuroprotective Activities of Palmitoylethanolamide in an Animal Model of Parkinson's Disease
por: Esposito, Emanuela, et al.
Publicado: (2012)

Cannabinoid Receptor Type 1 in Parkinson's Disease: A Positron Emission Tomography Study with [ (18)F]FMPEP‐d (2)
por: Ajalin, Riikka M., et al.
Publicado: (2022)

Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach
por: Mangano, Katia, et al.
Publicado: (2018)

Protective Role of Cannabinoid Receptor Type 2 in a Mouse Model of Diabetic Nephropathy
por: Barutta, Federica, et al.
Publicado: (2011)

Immunolocalization of cannabinoid receptor type 1 and CB2 cannabinoid receptors, and transient receptor potential vanilloid channels in pterygium
por: Assimakopoulou, Martha, et al.
Publicado: (2017)

Role of miRNAs in Alzheimer’s Disease and Possible Fields of Application
por: Silvestro, Serena, et al.
Publicado: (2019)

The role of cannabinoids in neurodevelopmental disorders of children and adolescents
por: de Freitas, Francisca Dias, et al.
Publicado: (2022)

Update on the Role of Cannabinoid Receptors after Ischemic Stroke
por: Capettini, Luciano S. A., et al.
Publicado: (2012)

Cannabinoids in Late Life Parkinson’s Disease and Dementia: Biological Pathways and Clinical Challenges
por: Costa, Alana C., et al.
Publicado: (2022)

Role of Cannabinoids in Obesity
por: Rossi, Francesca, et al.
Publicado: (2018)

Role of Vitamin E in the Treatment of Alzheimer’s Disease: Evidence from Animal Models
por: Gugliandolo, Agnese, et al.
Publicado: (2017)

Role of Cannabinoid CB2 Receptor in Alcohol Use Disorders: From Animal to Human Studies
por: García-Gutiérrez, María Salud, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g6angihr0tho8igdd34hgufmov